Group One Trading
SYRS

Group One Trading’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Group One Trading’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,620
Closed -$53K – 8877
2021
Q4 		$53K Buy
1,620
+430
+36% +$17.4K ﹤0.01% 6293
2021
Q3 		$53K Sell
1,190
-8,290
-87% -$405K ﹤0.01% 6506
2021
Q2 		$517K Buy
9,480
+220
+2% +$13K ﹤0.01% 4192
2021
Q1 		$693K Buy
9,260
+9,060
+4,530% +$941K ﹤0.01% 3662
2020
Q4 		$22K Hold
200
– – ﹤0.01% 5476
2020
Q3 		$18K Buy
+200
New +$22.7K ﹤0.01% 5184
2018
Q3 		– Sell
-740
Closed -$76K – 5688
2018
Q2 		$76K Buy
740
+160
+28% +$19.8K ﹤0.01% 3718
2018
Q1 		$75K Hold
580
– – ﹤0.01% 3432
2017
Q4 		$56K Buy
+580
New +$77.9K ﹤0.01% 3673

Other funds holding SYRS

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Group One Trading's SYRS Position: Q1 2025 in Review

Group One Trading sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2025, closing a stake of 3,355 shares — an estimated $771 sold.

Group One Trading first reported a position in SYRS in Q4 2017 and held it in 20 quarters. The position peaked at $127K in Q2 2021. 7 funds tracked by Wall St. Rank hold SYRS as of Q1 2025.

  • Group One Trading reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 3,355 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2025, an estimated $771.
  • Group One Trading first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 20 quarters.
  • Group One Trading's Syros Pharmaceuticals, Inc. Common Stock position peaked at $127K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.